The corporate regulator has brought proceedings against the Australian arm of Kraken Crypto Exchange, alleging it breached design and distribution obligations for a margin trading product that has lost customers almost $13 million.
The competition regulator has again raised concerns about how a planned acquisition by Dan Murphy’s owner Endeavour Group could affect competition in a local market for takeaway liquor. In a statement of issues released Thursday, the Australian Competition and Consumer Commission expressed preliminary worries that Endeavour’s purchase of the Rye Hotel on Victoria’s Mornington Peninsula…
The winning, 14 per cent contingency fee proposal by Slater & Gordon in a fight to run a class action against Star Entertainment was not driven by a desire to prevail in the contest and buy market share but was the product of a “reasoned decision” that took into account the law firm’s practice as a whole, a judge has found.
Class action boutique Bannister Law must bring a formal application to partner with a US-based law firm in proceedings against Hyundai and Kia over allegedly faulty anti-lock braking systems ahead of a fight with Maurice Blackburn to run the cases.
A judge has asked why the union representing Qantas workers did not bring a class action on behalf of 1,700 ground crew who were sacked during the COVID-19 pandemic, as he ordered the airline’s new CEO to attend settlement talks after losing its High Court appeal.
General Motors could be stuck paying more costs than it bargained for after it settled with the lead plaintiff in a class action over a decision to retire the Holden brand.
A judge has rejected the energy regulator’s claims that the owner of the Pelican Point power station in Adelaide failed to disclose its complete generator capacity to the energy market operator for months, contributing to rolling blackouts during a 2017 heatwave.
Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.
Sydney-based plastic surgeon Daniel Lanzer, who is facing a class action by 1,000 former patients, has been hit with a new lawsuit alleging he performed a negligent liposuction and fat transfer procedure, which left a woman with disfigurement, necrosis and nerve damage.
Another online trader has been hit with a class action by inexperienced investors who lost money while trading in risky derivatives slammed as little more than gambling products.